SpyGlass Pharma, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | — | — | $15.8M |
| FY2024 | $11.2M | $23.3M | $16.3M |
| FY2025 | $10.2M | $115.9M | $96.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | — | — | $15.8M |
| FY2024 | $11.2M | $23.3M | $16.3M |
| FY2025 | $10.2M | $115.9M | $96.4M |